Journal
BLOOD
Volume 124, Issue 3, Pages 374-384Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2014-01-514752
Keywords
-
Categories
Funding
- National Institutes of Health, National Cancer Institute [CA142106, CA183559, CA183560]
Ask authors/readers for more resources
Chronic graft-versus-host disease (GVHD) is a frequent and potentially life-threatening complication of allogeneic hematopoietic stem cell transplantation. Increased transplantation of older patients and the more frequent use of unrelated donors has led to increased numbers of patients with this painful complication. Recent advances have been made in understanding the pathophysiology of chronic GVHD and in establishing precise criteria for diagnosis and classification of disease manifestations. These advances will hopefully pave the way for improving both the prophylaxis and treatment of chronic GVHD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available